全文获取类型
收费全文 | 7929篇 |
免费 | 646篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 346篇 |
妇产科学 | 174篇 |
基础医学 | 964篇 |
口腔科学 | 253篇 |
临床医学 | 806篇 |
内科学 | 1598篇 |
皮肤病学 | 125篇 |
神经病学 | 431篇 |
特种医学 | 557篇 |
外国民族医学 | 14篇 |
外科学 | 893篇 |
综合类 | 148篇 |
一般理论 | 7篇 |
预防医学 | 1444篇 |
眼科学 | 68篇 |
药学 | 352篇 |
2篇 | |
中国医学 | 2篇 |
肿瘤学 | 428篇 |
出版年
2021年 | 93篇 |
2020年 | 79篇 |
2019年 | 82篇 |
2018年 | 129篇 |
2017年 | 100篇 |
2016年 | 74篇 |
2015年 | 120篇 |
2014年 | 171篇 |
2013年 | 229篇 |
2012年 | 269篇 |
2011年 | 249篇 |
2010年 | 209篇 |
2009年 | 175篇 |
2008年 | 266篇 |
2007年 | 285篇 |
2006年 | 262篇 |
2005年 | 274篇 |
2004年 | 206篇 |
2003年 | 192篇 |
2002年 | 196篇 |
2001年 | 197篇 |
2000年 | 211篇 |
1999年 | 152篇 |
1998年 | 195篇 |
1997年 | 194篇 |
1996年 | 230篇 |
1995年 | 262篇 |
1994年 | 253篇 |
1993年 | 229篇 |
1992年 | 260篇 |
1991年 | 248篇 |
1990年 | 213篇 |
1989年 | 182篇 |
1988年 | 185篇 |
1987年 | 172篇 |
1986年 | 178篇 |
1985年 | 173篇 |
1984年 | 137篇 |
1983年 | 108篇 |
1982年 | 86篇 |
1981年 | 84篇 |
1980年 | 69篇 |
1979年 | 81篇 |
1978年 | 73篇 |
1976年 | 74篇 |
1975年 | 59篇 |
1974年 | 69篇 |
1973年 | 59篇 |
1971年 | 51篇 |
1969年 | 49篇 |
排序方式: 共有8655条查询结果,搜索用时 62 毫秒
1.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
2.
3.
4.
5.
Diabetic polyneuropathy 总被引:1,自引:0,他引:1
6.
7.
8.
Over the last several decades the idea that adenosine (Ado) plays a role in sleep control was postulated due in large part to pharmacological studies that showed the ability of Ado agonists to induce sleep and Ado antagonists to decrease sleep. A second wave of research involving in vitro cellular analytic approaches and subsequently, the use of neurochemical tools such as microdialysis, identified a population of cells within the brainstem and basal forebrain arousal centers, with activity that is both tightly coupled to thalamocortical activation and under tonic inhibitory control by Ado. Most recently, genetic tools have been used to show that Ado receptors regulate a key aspect of sleep, the slow wave activity expressed during slow wave sleep. This review will briefly introduce some of the phenomenology of sleep and then summarize the effect of Ado levels on sleep, the effect of sleep on Ado levels, and recent experiments using mutant mouse models to characterize the role for Ado in sleep control and end with a discussion of which Ado receptors are involved in such control. When taken together, these various experiments suggest that while Ado does play a role in sleep control, it is a specific role with specific functional implications and it is one of many neurotransmitters and neuromodulators affecting the complex behavior of sleep. Finally, since the majority of adenosine-related experiments in the sleep field have focused on SWS, this review will focus largely on SWS; however, the role of adenosine in REM sleep behavior will be addressed. 相似文献
9.
10.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献